USFDA conducts inspection at Cipla’s manufacturing facility in Goa

22 Jun 2024 Evaluate

The United States Food and Drug Administration (USFDA) has conducted an inspection at the Cipla’s manufacturing facility in Goa, India from June 10, 2024 to June 21, 2024. On conclusion of the inspection, the company received 6 inspectional observations in Form 483. The company will work closely with the USFDA and is committed to address these comprehensively within stipulated time.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.


Cipla Share Price

1369.55 -8.30 (-0.60%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.55
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 876.10
Lupin 2139.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×